Spyre Therapeutics Inc.
10/02/2024 | Press release | Distributed by Public on 10/03/2024 04:02
Notice of Effectiveness - Form EFFECT
Notice of Effectiveness
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 2, 2024 4:15 P.M. |
| Form: | S-3 | |||||
|